This is a procedural proxy filing with no new financial information. The key catalyst to watch is the separate Conversion Special Meeting (date TBD) where stockholders will vote on converting the Series A Preferred Stock into common stock, which will determine the company's post-merger capital structure and Nasdaq listing outcome.
Price Chart
Executive Summary
Processa Pharmaceuticals is holding a special meeting on November 30, 2026, to seek stockholder approval for a reverse stock split (1-for-3 to 1-for-9 range) and an adjournment proposal. The reverse split is a procedural step required to meet Nasdaq's $4.00 minimum bid price initial listing criteria following the company's July 2026 merger with Vidya Therapeutics and a concurrent $200M PIPE financing, which together will result in a change of control (pre-merger stockholders will hold ~1.4% of the post-conversion common stock). The filing is routine and administrative — no financial results, executive compensation votes, or shareholder proposals are on the ballot.
Key Facts
- Special meeting on November 30, 2026 to vote on reverse stock split (1-for-3 to 1-for-9 range) and adjournment proposal
- Reverse split is required to meet Nasdaq's $4.00 minimum bid price for initial listing after the July 2026 Vidya merger and $200M PIPE
- Pre-merger stockholders will own ~1.4% of the post-conversion common stock; former Vidya holders ~46%; PIPE investors ~52.6%
- Board may abandon the reverse split at its discretion even if approved by stockholders
- No Say-on-Pay vote, director elections, or shareholder proposals are on the ballot at this special meeting
- CEO George Ng total compensation for FY2025 was $673,303 (salary $400K, bonus $50K, stock/option awards ~$199K)
- Company had a net loss of $13.6M in FY2025 and $11.9M in FY2024
Financial Impact
No direct financial impact from this filing. The reverse split is a mechanical share consolidation with no change to authorized shares or par value. The $200M PIPE gross proceeds were already raised in July 2026.
Risk Factors
- Reverse split may not achieve Nasdaq's $4.00 minimum bid price if the stock declines further
- If reverse split fails or Nasdaq listing application is denied, the Series A Preferred Stock cannot convert, potentially triggering adverse consequences under the merger and PIPE agreements
- Massive dilution: 306.6M shares issuable upon conversion of Series A Preferred Stock vs. 2.8M common shares outstanding currently
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001140361-26-040520 |
| Document: 0001140361-26-040520-index-headers.html | 0001140361-26-040520 |
| Document: 0001140361-26-040520-index.html | 0001140361-26-040520 |
| Document: 0001140361-26-040520.txt | 0001140361-26-040520 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | EFFECT | $1.80 | awaiting T+5 | — | $1.82 (−1.39%) |
Oct 22, 2026 5d ago | DEF 14A | $1.81 | awaiting T+5 | — | $1.82 (+0.55%) |
Oct 9, 2026 18d ago | S-3 | $1.90 $1.73 | ▲ +8.95% | ▲ +7.45% | $1.82 (+4.21%) |
Jul 29, 2026 12w ago | 8-K | $2.03 $2.19 | ▲ +7.88% | ▲ +2.35% | $1.82 (−10.34%) |
Jul 1, 2026 16w ago | Insider Cluster | $2.16 $2.16 | · 0.00% | ▼ −1.37% | $1.82 (−15.74%) |
Jun 16, 2026 19w ago | Insider Cluster | $2.15 $1.93 | ▼ −10.23% | ▼ −9.19% | $1.82 (−15.35%) |
Jun 16, 2026 19w ago | Insider Cluster | $2.15 $1.93 | ▼ −10.23% | ▼ −9.19% | $1.82 (−15.35%) |
Jun 1, 2026 21w ago | Insider Cluster | $2.92 $2.04 | ▼ −30.31% | ▼ −27.34% | $1.82 (−37.67%) |
May 19, 2026 23w ago | Insider Cluster | $2.61 $2.64 | ▲ +1.15% | ▼ −0.65% | $1.82 (−30.27%) |
May 19, 2026 23w ago | Insider Cluster | $2.61 $2.64 | ▲ +1.15% | ▼ −0.65% | $1.82 (−30.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers